James Strauss

3PUBLICATIONS
40CO-AUTHORS
AllergyMechanobiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 11, 2025
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.

Kevin J Harrington, Stephane Champiat, Joshua D Brody

|May 25, 2023
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.

Jason J Luke, Sarina A Piha-Paul, Theresa Medina

|Oct 06, 2021
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels.

Isabel Kurth, Norihiro Yamaguchi, Celia Andreu-Agullo

Pageof 1